https://www.thebodypro.com/category/hiv-epidemiology/tag/trans

The Latest

Johanne Morne and Dr. Oni Blackstock

Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work

Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.

long winding road through countryside

This Week in HIV Research: The Long Road to the End

Dec. 12, 2019: A lot of catchup to do before “Ending the HIV Epidemic”; the value of online HIV self-test distribution; viral suppression is about more than basic HIV treatment services; effect of hormone therapy on PrEP levels.

Billy Porter as Pray Tell in "Pose"

Black Gay Men in the Ballroom Scene Experience a Unique Form of HIV Prevention

Though not as widely studied, there are many ways that men who belong to the gay family networks of the ballroom scene may be getting an HIV intervention.

Man and woman holding hands

Trans Women Are Increasingly A Focus of HIV Programs, But What About their Cisgender Male Partners?

This population is under-represented in HIV data, and few prevention or treatment interventions exist to support them. A new meta-analysis hopes to paint a picture of what's needed.

Prison Cells

Strong Peer Networks in Prison Boost Overall Health, Study Finds

But other research links prisons themselves to mental health challenges and infectious disease outbreaks.

broken heart with zig-zag thread holding it together embroidery

This Week in HIV Research: My Achy-Breaky Heart

Sep. 5, 2019: An extra decade of "heart age"; stop grouping trans women with MSM; women often have anal cancer precursor lesions; hep C treatment success doesn't equal more risk behavior.

man getting vaccine

Large Scale HIV Vaccine Trial Announced, But PrEP May Challenge Enrollment

Will potential study participants choose a vaccine trial over getting access to PrEP?

Fist raised at Black Lives Matter Protest

This Week in HIV Research: The Racism of Perceived Risk

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

AIDS Activists Hold March And Rally In New York City

Ending the HIV Epidemic Will Take More Than Medicine

Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.

scientists in Vaccine Research Center at National Institutes of Health

Making Trans Women Count in HIV Vaccine Trials

"For us who focus on HIV prevention research, it is paramount that we go where the epidemic is in this country," said Michele Andrasik, Ph.D.